[HTML][HTML] Progranulin as a therapeutic target in neurodegenerative diseases

H Rhinn, N Tatton, S McCaughey, M Kurnellas… - Trends in …, 2022 - cell.com
Progranulin (PGRN, encoded by the GRN gene) plays a key role in the development,
survival, function, and maintenance of neurons and microglia in the mammalian brain. It …

[HTML][HTML] Lysosome dysfunction as a cause of neurodegenerative diseases: Lessons from frontotemporal dementia and amyotrophic lateral sclerosis

J Root, P Merino, A Nuckols, M Johnson… - Neurobiology of disease, 2021 - Elsevier
Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are fatal
neurodegenerative disorders that are thought to exist on a clinical and pathological …

Frontotemporal lobar degeneration

M Grossman, WW Seeley, AL Boxer, AE Hillis… - Nature Reviews …, 2023 - nature.com
Frontotemporal lobar degeneration (FTLD) is one of the most common causes of early-onset
dementia and presents with early social–emotional–behavioural and/or language changes …

Diagnostic contribution and therapeutic perspectives of transcranial magnetic stimulation in dementia

V Di Lazzaro, R Bella, A Benussi, M Bologna… - Clinical …, 2021 - Elsevier
Transcranial magnetic stimulation (TMS) is a powerful tool to probe in vivo brain circuits, as it
allows to assess several cortical properties such as excitability, plasticity and connectivity in …

[HTML][HTML] C9ORF72: what it is, what it does, and why it matters

J Smeyers, EG Banchi, M Latouche - Frontiers in cellular …, 2021 - frontiersin.org
When the non-coding repeat expansion in the C9ORF72 gene was discovered to be the
most frequent cause of frontotemporal dementia (FTD) and amyotrophic lateral sclerosis …

[HTML][HTML] Rapidly progressive dementias—aetiologies, diagnosis and management

P Hermann, I Zerr - Nature Reviews Neurology, 2022 - nature.com
Rapidly progressive dementias (RPDs) are a group of heterogeneous disorders that include
immune-mediated, infectious and metabolic encephalopathies, as well as prion diseases …

Genetics of Parkinson's disease

A Cherian, KP Divya - Acta Neurologica Belgica, 2020 - Springer
Less than a quarter century after the discovery of SNCA as the first attributable gene in
Parkinson's disease (PD), our knowledge of the genetic architecture underlying this disease …

Preventing amyotrophic lateral sclerosis: insights from pre-symptomatic neurodegenerative diseases

M Benatar, J Wuu, C McHutchison, RB Postuma… - Brain, 2022 - academic.oup.com
Significant progress has been made in understanding the pre-symptomatic phase of
amyotrophic lateral sclerosis. While much is still unknown, advances in other …

[HTML][HTML] Preclinical evaluation of WVE-004, an investigational stereopure oligonucleotide for the treatment of C9orf72-associated ALS or FTD

Y Liu, A Andreucci, N Iwamoto, Y Yin, H Yang… - … Therapy-Nucleic Acids, 2022 - cell.com
A large hexanucleotide (G 4 C 2) repeat expansion in the first intronic region of C9orf72 is
the most common genetic cause of amyotrophic lateral sclerosis (ALS) and frontotemporal …

Neuropathology and emerging biomarkers in corticobasal syndrome

S Koga, KA Josephs, I Aiba, M Yoshida… - Journal of Neurology …, 2022 - jnnp.bmj.com
Corticobasal syndrome (CBS) is a clinical syndrome characterised by progressive
asymmetric limb rigidity and apraxia with dystonia, myoclonus, cortical sensory loss and …